Patents by Inventor Timothy Triche

Timothy Triche has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treating ewing sarcoma
    Patent number: 9956176
    Abstract: Provided herein are compositions and methods for treating cancer in a subject in need thereof. The methods include using hybrid polymerized liposomal nanoparticles comprising, both polymerizable lipids and non-polymerizable lipids. The nanoparticles further comprise targeting agents and therapeutic agents.
    Type: Grant
    Filed: January 23, 2017
    Date of Patent: May 1, 2018
    Assignees: Children's Hospital Los Angeles, Nanovalent Pharmaceuticals, Inc.
    Inventors: Jon O. Nagy, Timothy Triche, Hyung-Gyoo Kang, Sheetal Mitra
  • COMPOSITIONS AND METHODS FOR TREATING EWING SARCOMA
    Publication number: 20170143630
    Abstract: Provided herein are compositions and methods for treating cancer in a subject in need thereof. The methods include using hybrid polymerized liposomal nanoparticles comprising, both polymerizable lipids and non-polymerizable lipids. The nanoparticles further comprise targeting agents and therapeutic agents.
    Type: Application
    Filed: January 23, 2017
    Publication date: May 25, 2017
    Applicants: Children's Hospital Los Angeles, Nanovalent Pharmaceuticals, Inc.
    Inventors: Jon O. Nagy, Timothy Triche, Hyung-Gyoo Kang, Sheetal Mitra
  • Methods and compositions for the targeted delivery of therapeutics
    Publication number: 20070202076
    Abstract: Disclosed herein are compositions and methods for the targeted delivery of a therapeutic agent. In one aspect, the invention pertains to glycopolymer-based particles complexed with a nucleic acid-based therapeutic. Other aspects of the invention relate to methods for treating various conditions by administering the particle compositions of the invention. In some embodiments, a cyclodextrin-based particle is used to deliver siRNA against one or more oncogenes.
    Type: Application
    Filed: March 24, 2006
    Publication date: August 30, 2007
    Inventors: Timothy Triche, Siwen Hu